Category Archives: Patently BIOtech

Technology Transfer Symposium at BIO Investor Forum

   Technology Transfer Symposium: Promoting Public-Private Collaboration for Innovation Wednesday October 28, 2009 7:30 am – 12 pm PT The Palace Hotel San Francisco, CA The Technology Transfer Symposium, held in conjunction with the BIO Investor Forum, will explore the domestic and international policy challenges for professionals in university, industry, and legal areas regarding the administration of technology transfer.  This groundbreaking meeting will bring together stakeholder groups to discuss the challenges and opportunities of today’s Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: ,

New Series: Biotechnology Companies at Forefront of Global Health Innovation – Post #1: GlaxoSmithKline & Alnylam Pharmaceuticals

On July 8 2009, GlaxoSmithKline (GSK) and Alnylam Pharmaceuticals, Inc. announced a patent pool to compile intellectual property (IP) to develop treatments for 16 tropical diseases as identified by the FDA including malaria, TB and Chagas, found in 49 Least Developed Countries as defined by the United Nations.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , ,

Webinar: University Startups: Best Practices

Update: The presentation materials are available here: (thanks to Jack Pincus, via Twitter) The National Council of Entrepreneurial Tech Transfer (NCET2) is hosting a webinar on university spinouts and the MIT entrepreneurial ecosystem: What Are Universities Doing to Create and Fund University Startups: Best Practices The MIT Entrepreneurial Ecosystem Wednesday, July 29, 1:00-2:30pm ET (10:00-11:30am PT) With Edward B. Roberts (David Sarnoff Professor of the Management of Technology MIT Sloan School of Management; Founder/Chair, MIT Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post

GAO Report on Bayh-Dole: Leverage to Promote Commercialization of Federally-Funded Inventions

The General Accountability Office submitted its report to Congress today on the administration of the regulations found under the Bayh-Dole Act, the foundation of all federally-funded research in the United States and one of the key factors in the creation (and boom) of biotechnology as both a research field and industry in the 1980s. A little background on Bayh-Dole: Technological innovation is widely seen as responsible for much of the economic growth and increased standard Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Department of State: Foster Climate Change Solutions, Biodiversity, & Economic Development with IPR Protections

CropLife has recently published their newest video interview last week with Carrie LaCrosse, of the Office of Intellectual Property Enforcement at the U.S. Department of State. LaCrosse discusses the value of IP for agriculture, looking in particular at new plant varieties and how IP is part of the solution in addressing the issues of food security.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , ,